# Monopar Therapeutics: Form SC 13D/A, filed Dec 17, 2024

- Company: [Monopar Therapeutics](/companies/mnpr.md) (CIK 1645469)
- Form: SC 13D/A
- Filed: 2024-12-17
- Accepted by EDGAR: Dec 17, 2024, 22:01 ET
- Period: not reported
- Accession: 0001437749-24-037745
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1645469/000143774924037745/tpllc20241217_sc13da.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1645469/000143774924037745/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1645469/000143774924037745/tpllc20241217_sc13da.htm

Filed Dec 17, 2024.
Source: SEC EDGAR, the filing index for accession 0001437749-24-037745. Last ingested by Listed: Oct 24, 2026, 15:14 ET. No prices; not investment advice.